ITIH3_RABIT
ID ITIH3_RABIT Reviewed; 903 AA.
AC Q9GLY5;
DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2001, sequence version 1.
DT 25-MAY-2022, entry version 70.
DE RecName: Full=Inter-alpha-trypsin inhibitor heavy chain H3;
DE Short=ITI heavy chain H3;
DE Short=ITI-HC3;
DE Short=Inter-alpha-inhibitor heavy chain 3;
DE Flags: Precursor;
GN Name=ITIH3;
OS Oryctolagus cuniculus (Rabbit).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX NCBI_TaxID=9986;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RA Suzuki A.;
RT "Rabbit inter-alpha-trypsin inhibitor heavy chain.";
RL Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: May act as a carrier of hyaluronan in serum or as a binding
CC protein between hyaluronan and other matrix protein, including those on
CC cell surfaces in tissues to regulate the localization, synthesis and
CC degradation of hyaluronan which are essential to cells undergoing
CC biological processes. {ECO:0000250}.
CC -!- SUBUNIT: I-alpha-I plasma protease inhibitors are assembled from one or
CC two heavy chains (HC) and one light chain, bikunin. Pre-alpha-inhibitor
CC (P-alpha-I) is composed of ITIH3/HC3 and bikunin.
CC {ECO:0000250|UniProtKB:Q06033}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC -!- PTM: Heavy chains are linked to bikunin via chondroitin 4-sulfate
CC esterified to the alpha-carboxyl of the C-terminal aspartate after
CC propeptide cleavage. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the ITIH family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB050593; BAB17302.1; -; mRNA.
DR RefSeq; NP_001075477.1; NM_001082008.1.
DR AlphaFoldDB; Q9GLY5; -.
DR SMR; Q9GLY5; -.
DR STRING; 9986.ENSOCUP00000018231; -.
DR PRIDE; Q9GLY5; -.
DR GeneID; 100008624; -.
DR KEGG; ocu:100008624; -.
DR CTD; 3699; -.
DR eggNOG; ENOG502QPS2; Eukaryota.
DR InParanoid; Q9GLY5; -.
DR OrthoDB; 955432at2759; -.
DR Proteomes; UP000001811; Unplaced.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0030212; P:hyaluronan metabolic process; IEA:InterPro.
DR Gene3D; 3.40.50.410; -; 1.
DR InterPro; IPR010600; ITI_HC_C.
DR InterPro; IPR013694; VIT.
DR InterPro; IPR002035; VWF_A.
DR InterPro; IPR036465; vWFA_dom_sf.
DR Pfam; PF06668; ITI_HC_C; 1.
DR Pfam; PF08487; VIT; 1.
DR Pfam; PF00092; VWA; 1.
DR SMART; SM00609; VIT; 1.
DR SMART; SM00327; VWA; 1.
DR SUPFAM; SSF53300; SSF53300; 1.
DR PROSITE; PS51468; VIT; 1.
DR PROSITE; PS50234; VWFA; 1.
PE 2: Evidence at transcript level;
KW Glycoprotein; Protease inhibitor; Proteoglycan; Reference proteome;
KW Secreted; Serine protease inhibitor; Signal.
FT SIGNAL 1..20
FT /evidence="ECO:0000255"
FT PROPEP 21..34
FT /evidence="ECO:0000250"
FT /id="PRO_0000312434"
FT CHAIN 35..663
FT /note="Inter-alpha-trypsin inhibitor heavy chain H3"
FT /id="PRO_0000312435"
FT PROPEP 664..903
FT /evidence="ECO:0000250"
FT /id="PRO_0000312436"
FT DOMAIN 29..158
FT /note="VIT"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00801"
FT DOMAIN 284..467
FT /note="VWFA"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT MOD_RES 663
FT /note="Aspartate 1-(chondroitin 4-sulfate)-ester"
FT /evidence="ECO:0000250"
FT CARBOHYD 91
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 580
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
SQ SEQUENCE 903 AA; 100754 MW; 12D0B1518DF9C933 CRC64;
MASAQWLGLV LALLSSLAAS GFPGSPFRLL GKRSLPEGAV NGIEIYSTKI NCKVTSRFAH
NVVTTRAVNR ADTAKEVSFD VELPKTAFIT NFTLTIDGVT YPGHVKEKEV AKKQYEKAVS
QGKTAGLVKA SGRKLEKFTV SVNVAAGSKV TFELTYEELL KRHKGKYEMY LKVQPKQLVK
HFEIDAHIFE PQGISMLDAE ASFITNDLLG SALTKSFSGK KGHVSFKPSL DQQRSCPTCT
DSLLNGDFTI TYDVNRESPA NIQIVNGYFV HFFAPQGLPV VPKNVVFVID VSGSMYGRKL
EQTKDALLKI LEDMREEDHL NFILFSSDVT TWKEHLVQAT PENLQEARAF VKSIQDQGST
NLNDGLLRGI SMLNTAREEH RVPERSTSIV IMLTDGDANS GESRPEKIQE NVRNAIGGKF
PLYNLGFGNN LNYNFLESLA LENDGFARRI YEDSDANLQL HGFYEEVANP LLTSVEMEYP
KNAILDLTQN SYQHFYDGSE IVVAGRLADE DMNSFKADVK GHGALNDLTF TEEVDLKETE
AALKEREYIF GNYIERLWAY LTIEQLLEKR KNARGEEKEN LTAQALDLSL KYHFVTPLTS
MVVTKPEDNE DQTAIADKPG EEQAQAASQT SFSAYRTSYQ PPLGSAASYQ PPLGTPYYYV
DGDPHFIIQV PEQDNAICFN IDEEPGTVLR LIQDPATGLT VNGQIIGDKK SSPDSATRKT
YFGKLGIASA HMDLRIEVTT EKISLWNEVG RSTFSWLDTV TVTQDGLSMT INRKKNMVVS
FGEGVTFVVI LHQVWKNHPI HQDFLGFYVV DSHRMSAWTH GLLGQFFHPF DFKVSDVHPG
SEPTKPDATM VVKNRQLTVT RGSQRDYRMD ARAGTKVACW FVHNNGEGLI DGVHTDYIVP
NLF